Dentsply Sirona director receives RSU share grant

DENTSPLY SIRONA Inc. director Donald Zurbay reported a compensation-related equity grant.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Donald Zurbay reported a compensation-related equity grant. He acquired 22,822 shares of common stock through a grant coded as an award, with no cash price per share. These are in the form of Restricted Stock Units that vest in full one year from the grant date. After this grant, his directly held common stock position reported in the filing is 29,693 shares.

Insider Trade Summary

Grant/Award: 22,822 shares

Grant/Award 1 txn

Insider Zurbay Donald

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,822	$0.00	$0.00

Holdings After Transaction: Common Stock — 29,693 shares (Direct)

Footnotes (1)

F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSU grant size: 22,822 shares Grant price per share: $0.0000 per share Shares after grant: 29,693 shares +1 more

4 metrics

RSU grant size 22,822 shares Grant of common stock on transaction date

Grant price per share $0.0000 per share Compensation-related award, not open-market trade

Shares after grant 29,693 shares Total directly held common stock following transaction

Vesting schedule 1 year from grant date RSUs vest in full after one year

Key Terms

Restricted Stock Units (RSUs), Grant, award, or other acquisition, Form 4, transaction code A

4 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code A financial

"transaction_code: "A""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DENTSPLY SIRONA (XRAY) director Donald Zurbay report on this Form 4?

Donald Zurbay reported receiving a grant of 22,822 shares of DENTSPLY SIRONA common stock. The grant is recorded as a compensation-related award, increasing his directly held position to 29,693 shares according to the filing’s post-transaction ownership line.

Was the DENTSPLY SIRONA (XRAY) Form 4 transaction a market purchase or sale?

The Form 4 shows an equity grant, not a market trade. The transaction code is A, indicating a grant or award acquisition, and the price per share is listed as $0.0000, typical for stock-based compensation rather than open-market buying or selling.

How many DENTSPLY SIRONA (XRAY) shares were granted to Donald Zurbay?

The filing reports a grant of 22,822 shares of common stock. These shares are tied to Restricted Stock Units that vest in full one year from the grant date, subject to the conditions described in the grant terms referenced in the footnote.

What is Donald Zurbay’s DENTSPLY SIRONA (XRAY) shareholding after the reported grant?

After the grant, Donald Zurbay’s directly held common stock position is reported as 29,693 shares. This figure reflects his holdings immediately following the award transaction disclosed in the Form 4 and does not include any additional future grants or vesting events.

What vesting terms apply to the DENTSPLY SIRONA (XRAY) RSU grant reported?

The grant consists entirely of Restricted Stock Units that vest in full one year from the date of grant. Until vesting, the units remain subject to restrictions, and the lapse of those restrictions is what converts them into fully vested shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/05/2026 - 05:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zurbay Donald

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

NORTH CAROLINA

28277

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/03/2026		A		22,822⁽¹⁾	A	$0	29,693	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Donald J. Zurbay	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR